Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 124

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice

Tang, Xiuwei, Zhu, Yucui, Han, Lydia, Kim, Arianna L., Kopelovich, Levy, Bickers, David R., Athar, Mohammad · 2007 · Journal of Clinical Investigation

Abstract

Mutations in the tumor suppressor p53 are detectable in over 50% of all human malignancies. Mutant p53 protein is incapable of transactivating its downstream target genes that are required for DNA repair and apoptosis. Chronic exposure to UVB induces p53 mutations and is carcinogenic in both murine and human skin. CP-31398, a styrylquinazoline compound, restores the tumor suppressor functions of mutant forms of p53 in tumor cells. However, its effectiveness in vivo remains unclear. Here, we demonstrate that CP-31398 blocked UVB-induced skin carcinogenesis and was associated with increases in p53, p21, and BclXs. CP-31398 downregulated Bcl2, proliferating nuclear cell antigen, and cyclin D1. Activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase also occurred in both tumor and perilesional skin following treatment. CP-31398 induced the expression of p53-dependent target proteins, and this was followed by apoptosis in UVB-irradiated wild-type mice but not in their p53-deficient littermates. Similar effects were observed in human skin carcinoma A431 cells expressing mutant p53. In addition, CP-31398 induced mitochondrial translocation of p53, leading to changes in mitochondrial membrane permeability pore transition (MPT) and consequent cytochrome c release in these cells. Blocking MPT diminished p53 translocation and apoptosis. These studies indicate that reconstituting p53 tumor suppressor functions in vivo by small molecular weight compounds may block the pathogenesis and progression of skin cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci32481

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 17

  1. van Kranen, 1999, J. Epidemiol., 9, S58, 10.2188/jea.9.6sup_58 · DOI
  2. Mitchell, 1989, Photochem. Photobiol., 49, 805, 10.1111/j.1751-1097.1989.tb05578.x · DOI · Paper page
  3. van Kranen, 2005, Mutat. Res., 571, 81, 10.1016/j.mrfmmm.2004.07.018 · DOI
  4. Roth, 2003, Methods Mol. Biol., 223, 577
  5. Wang, 2003, Cancer Biol. Ther., 2, S55
  6. Bickers, 2000, J. Dermatol., 27, 691, 10.1111/j.1346-8138.2000.tb02259.x · DOI
  7. Starcher, 1995, Ciba Found. Symp., 192, 338
  8. Takimoto, 2004, Gan To Kagaku Ryoho., 31, 1309
  9. Reiss, 1992, Oncol. Res., 4, 349
  10. Park, 1994, Oncogene., 9, 1899
  11. Ogawa, 2004, Int. J. Mol. Med., 13, 69
  12. Chaoui, 2006, Cytometry B Clin. Cytom., 70, 189, 10.1002/cyto.b.20100 · doi:10.1002/cyto.b.20100
  13. McDonald, 2000, Int. J. Oncol., 16, 871
  14. Takimoto, 2002, Cancer Biol. Ther., 1, 47, 10.4161/cbt.1.1.41 · DOI
  15. Wang, 2005, Cancer Biol. Ther., 4, 893, 10.4161/cbt.4.8.2134 · DOI
  16. Luo, 2001, Cancer Res., 61, 8158
  17. Mihara, 2003, Mol. Cell., 11, 577, 10.1016/S1097-2765(03)00050-9 · DOI · Paper page

Cited by

See all 124

Metadata

Authors
Tang, X., Zhu, Y., Han, L., Kim, A. L., Kopelovich, L., Bickers, D. R., & Athar, M.
Venue
Journal of Clinical Investigation
Published
2007-12-03
Volume
117
Issue
12
Pages
3753-3764
ISSN
0021-9738
Cited by
124
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.